The company offers Enhertu to treat patients with HER2 positive ... an oral treatment which lowers cholesterol; Nustendi, a fixed-dose combination tablet of bempedoic acid and ezetimibe to reduce ...

like AstraZeneca's Enhertu (trastuzumab deruxtecan), which required treatment discontinuation. There were nine deaths across the two dose groups, with one deemed treatment-related (in the 12 mg/kg ...

Mylotarg was reintroduced in 2017 after the FDA cleared it at a lower dose for a subset of leukaemia ... One industry leading example of this evolution is Enhertu. Launched in 2019 for HER2 ...

Breast cancer remains the most common cancer among women globally, and Germany stands at the forefront of offering advanced and effective treatment options. Through a combination of high medical ...

Stay up-to-date with the latest and best audio content from CBC Listen delivered to your inbox every two weeks.